Immunosyn Corp. Revenue, Profits - IMYN Annual Income Statement

Add to My Stocks
$0 $0 (0%) IMYN stock closing price Jul 09, 2015 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Immunosyn Corp. stock price alone is not sufficient. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $- for 2009 impacts the IMYN stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the Immunosyn Corp. profit and loss statement for 2009 total to $0. This line item shows that the operating expenses has decreased compared with last year. Also check: Immunosyn Corp. assets and Immunosyn Corp. free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec2009
Immunosyn Corp. Revenues or Net Sales
-
Cost Of Goods Sold (COGS)-
Immunosyn Corp. Gross Profit
-
Research & Development Expense-
Selling General & Admin Expense-
Income Before Depreciation Depletion Amortization-0.73M
Depreciation Depletion Amortization-
Non Operating Income-1.94M
Interest Expense-
Immunosyn Corp. Pretax Income
-2.77M
Provision for Income Taxes-
MinorityInterest-
Investment Gains Losses-
Other Income-
Income Before Extraordinaries & Disc Operations-2.77M
Extraordinary Items & Discontinued Operations-
Immunosyn Corp. Profit/ Loss (Net Income)
-2.77M
Average Shares used to compute Diluted EPS270.67M
Average Shares used to compute Basic EPS270.67M
Income Before Nonrecurring Items-2.77M
Income from Nonrecurring Items-
Immunosyn Corp. Earnings Per Share Basic Net
-0.01
Immunosyn Corp. Earnings Per Share Diluted Net
-0.01
EPS Diluted Before Nonrecurring Items-0.01
Preferred Dividends Acc Pd-
Dividends Common-
Dividend Per Share Common0.00
All figures in USD. M: Millions of USD, B: Billions of USD.

It is very helpful to read a report on Immunosyn Corp. stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Immunosyn Corp. revenue chart implies that the company is growing. It has been the case with Immunosyn Corp.. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-2.77M for Immunosyn Corp. for 2009. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the IMYN income statement, one can check the Immunosyn Corp. historical stock prices to check how the price has moved with time.